Public Policy

Does the GOP Health Plan Offer Choice or a Blindfold?
Public Policy Does the GOP Health Plan Offer Choice or a Blindfold?

The promise of placing healthcare decisions firmly in the hands of the consumer has long been a powerful political ideal, suggesting a future where individuals can navigate the market with the same confidence they use to choose a car or a smartphone. Yet, a new Republican proposal designed to

Is Healthcare Reform Ignoring Doctors' Voices?
Public Policy Is Healthcare Reform Ignoring Doctors' Voices?

As nations around the globe grapple with the monumental task of reshaping their healthcare systems, a critical question emerges from the frontlines of patient care: are the architects of reform listening to the very professionals tasked with implementing their ambitious plans? Sweeping policy

Senate Fails to Prevent ACA Premium Hikes for Millions
Public Policy Senate Fails to Prevent ACA Premium Hikes for Millions

The financial stability of millions of American households now hangs precariously in the balance following a congressional stalemate that promises to trigger a severe healthcare affordability crisis. Without legislative intervention, a critical support system that has made health insurance

How Mediation Restores Trust in Patient Care
Public Policy How Mediation Restores Trust in Patient Care

When a breakdown in communication between a patient and a healthcare provider escalates into a formal dispute, the ensuing legal battle often inflicts a second, more insidious wound by destroying the very trust that underpins effective care. The traditional path of litigation, with its adversarial

Can Trump Lower Health Costs Without Congress?
Public Policy Can Trump Lower Health Costs Without Congress?

Introduction: The Executive Path to Healthcare Affordability With the average annual premium for family health insurance climbing toward an unsustainable thirty thousand dollars, the question of how to meaningfully reduce healthcare costs has become one of the most urgent economic challenges facing

Non-Profit's Gene Therapy for Rare Disease Wins FDA Approval
Public Policy Non-Profit's Gene Therapy for Rare Disease Wins FDA Approval

In a landmark decision that redefines the boundaries of pharmaceutical innovation, the U.S. Food and Drug Administration has officially approved a groundbreaking gene therapy developed not by a corporate giant, but by an Italian non-profit foundation, offering a potential cure for a devastating

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later